STEMCELL Technologies to Co-Sponsor the Foremost Event of the Year in Stem Cell Science More
Keynote from Dr. Alibay, an Aerospace Engineer working on robotic missions that explore our solar system, will headline an action-packed
The integration of Immunodiagnostic Systems (IDS) products into the Euroimmun portfolio has created a unique and broad menu of speciality
Anyone who has got a pet rat at home knows how intelligent and adaptable these animals are. And they are
Vector-borne diseases such as dengue, chikungunya, Zika and West Nile fever account for more than 17% of all infectious diseases
If a child grows significantly slower or is much smaller than their peers, parents generally get worried. While this may
On 15th April 2025, the European Commission authorised lecanemab (monoclonal anti-amyloid (beta) antibody; trade name: Leqembi from Eisai and Biogen)
New instrument automates tissue processing for researchers in cancer, immunology and other science fields VANCOUVER, BRITISH COLUMBIA, June 27, 2025 –
Vancouver, British Columbia and Cambridge, United Kingdom, June 2, 2025 – STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce